Mitochondrial dynamics in the neonatal brain - a potential target following injury?

Adam Jones1, Claire Thornton2

  • 1Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, U.K.

Bioscience Reports
|March 23, 2022
PubMed

Insights

Hypoxic-ischaemic (HI) brain injury from birth asphyxia causes significant neuronal death due to mitochondrial dysfunction. Targeting mitochondrial dynamics offers new therapeutic strategies for brain injury.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Birth asphyxia can lead to hypoxic-ischaemic (HI) brain injury, a condition with severe, long-term consequences for infants and families.
  • Current treatments like therapeutic hypothermia have limitations and are not accessible globally.
  • Mitochondrial dysfunction, including outer membrane permeabilisation and altered dynamics (fission/fusion), is a key factor in neuronal death following HI insult.

Purpose of the Study:

  • To introduce the molecular mechanisms and pathways governing mitochondrial dynamics.
  • To explain how these pathways are regulated and disrupted by HI insult.
  • To review drug repurposing strategies targeting mitochondrial dynamics for potential therapeutic interventions.

Main Methods:

  • Literature review of molecular players and pathways in mitochondrial dynamics.
  • Analysis of how HI insult affects mitochondrial regulation.
  • Survey of existing drugs that could be repurposed to target mitochondrial dynamics.

Main Results:

  • Mitochondrial dynamics, involving fission and fusion proteins, are critical in HI brain injury.
  • HI insults trigger mitochondrial dysfunction, leading to apoptosis.
  • Several approved drugs show potential for repurposing to modulate mitochondrial dynamics.

Conclusions:

  • Mitochondrial dynamics represent a promising therapeutic target for HI brain injury.
  • Drug repurposing offers a fast-track, low-cost approach to developing new treatments.
  • Further research into targeting mitochondrial dynamics could significantly improve outcomes for infants with brain injury.